Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? – Results from the randomized DAHANCA 5 and 7 trials

(2011) Camilla Molich Hoff et al.   ACTA ONCOLOGICA

Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer

(2011) K. Toustrup et al.   CANCER RESEARCH

8503 ORAL A Prospective Study Evaluating the Influence of Smoking on Effective Hemoglobin Level and Outcome in Patients With Squamous Cell Carcinoma of the Head and Neck

(2011) C. Hoff et al.   EUROPEAN JOURNAL OF CANCER

Management of anemia in cancer patients

(2011) Aknar Calabrich et al.   Future Oncology

Acute Versus Chronic Hypoxia: Why a Simplified Classification is Simply Not Enough

(2011) Christine Bayer et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis

(2011) Jens Overgaard   RADIOTHERAPY AND ONCOLOGY

Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck

(2011) Kasper Toustrup et al.   RADIOTHERAPY AND ONCOLOGY

Identifying hypoxia in human tumors: A correlation study between18F-FMISO PET and the Eppendorf oxygen-sensitive electrode

(2010) Lise Saksø Mortensen et al.   ACTA ONCOLOGICA

Head and Neck Cancer Among Lifelong Never-Smokers and Ever-Smokers

(2010) Allen M. Chen et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Tobacco Smoking During Radiation Therapy for Head-and-Neck Cancer Is Associated With Unfavorable Outcome

(2010) Allen M. Chen et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

(2010) K. Kian Ang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Erythropoiesis stimulating agents, thrombosis and cancer

(2010) Lisa Barbera et al.   RADIOTHERAPY AND ONCOLOGY

The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome

(2010) Pernille Lassen   RADIOTHERAPY AND ONCOLOGY

The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy – Results from the randomized DAHANCA 5 study

(2010) Camilla Molich Hoff et al.   RADIOTHERAPY AND ONCOLOGY

Cause-specific mortality associated with leukoreduced, buffy coat-depleted, or no blood transfusion after elective surgery for colorectal cancer: a posttrial 15-year follow-up study

(2010) Frank V. Mortensen et al.   TRANSFUSION

Effect of Epoetin Alfa on Survival and Cancer Treatment–Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer

(2009) Peter J. Hoskin et al.   JOURNAL OF CLINICAL ONCOLOGY

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

(2009) Julia Bohlius et al.   LANCET

Anemia Management in Oncology and Hematology

(2009) J. L. Spivak et al.   ONCOLOGIST

Evaluating Erythropoietin-Associated Tumor Progression Using Archival Tissues from a Phase III Clinical Trial

(2009) Chris P. Miller et al.   STEM CELLS

Erythropoietin in Cancer Patients

(2008) John A. Glaspy   Annual Review of Medicine

Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis

(2008) P. Vaupel   ONCOLOGIST

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

(2007) Gillian Thomas et al.   GYNECOLOGIC ONCOLOGY